Abstract:Background: Esophageal squamous cell carcinoma (ESCC), a prevalent malignancy within the upper gastrointestinal system, is characterized by its unfavorable prognosis and the absence of specific indicators for outcome prediction and high-risk case identification. In our research, we examined the expression levels of cancer stem cells (CSCs), markers CD44/SOX2 in ESCC, scrutinized their association with clinicopathological parameters, and developed a predictive nomogram model. This model, which incorporates CD44/SOX2, aims to forecast the overall survival (OS) of patients afflicted with ESCC. Methods: Immunohistochemistry was utilized to detect the expression levels of CD44 and SOX2 in both cancerous and paracancerous tissues of 68 patients with ESCC. The correlation between CD44/SOX2 expression and clinicopathological parameters was subsequently analyzed. Factors impacting the prognosis of ESCC patients were assessed through univariate and multivariate Cox regression analyses. Leveraging the results of these multivariate regression analyses, a nomogram prognostic model was established to provide individualized predictions of ESCC patient survival outcomes. The predictive accuracy of the nomogram prognostic model was evaluated using the consistency index (C-index) and calibration curves. Results: The expression levels of CD44 were markedly elevated in the tumor tissues of ESCC patients. Similarly, SOX2 was significantly overexpressed in the tumor tissues of ESCC patients. The positive expression of SOX2 in ESCC demonstrated a strong correlation with both the pathological T-stage and the presence of carcinoembryonic antigen. CD44 and SOX2 co-positive expression was significantly associated with the pathological T-stage and tumor node metastasis (TNM) stage. Furthermore, ESCC patients exhibiting CD44-positive expression in their tumor tissue generally had a more adverse prognosis. The co-expression of CD44 and SOX2 resulted in a grimmer prognosis compared to patients with other combinations. Multivariate Cox regression analysis identified the co-expression of CD44 and SOX2, the pathological T-stage, and lymph node metastasis as independent prognostic indicators for ESCC patients. The three identified variables were subsequently incorporated into a nomogram for predicting OS. The C-index of the measurement model and the area under the curve of the subjects' work characteristics showed good individual prediction. This prognostic model stratified patients into low- and high-risk categories. Analysis revealed that the 5-year OS rate was significantly higher in the low-risk group compared to the high-risk group. Conclusions: Elevated CD44 levels, indicative of CSC presence, are intimately linked with the oncogenesis of ESCC and are strongly predictive of unfavorable patient outcomes. Concurrently, the SOX2 gene exhibits a heightened expression in ESCC, markedly accelerating tumor progression and fostering more extensive disease infiltration. The co-expression of CD44 and SOX2 correlates significantly with ESCC patient prognosis, serving as a reliable, independent prognostic marker. Our constructed nomogram, incorporating CD44/SOX2 expression, enhances the prediction of OS and facilitates risk stratification in ESCC patients.

SOX2 Amplification and Chromosome 3 Gain Significantly Impact Prognosis in Esophageal Squamous Cell Carcinoma

Prevalence of Gene Amplifications of Sox-2, C-Met, and Fgfr1 in Asian Patients with Esophageal Squamous Cell Carcinoma.

Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy

SOX12 Contributes to the Activation of the JAK2/STAT3 Pathway and Malignant Transformation of Esophageal Squamous Cell Carcinoma

CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated with Better Patient Outcome

Clinicopathological significance of cancer stem cell marker CD44/SOX2 in esophageal squamous cell carcinoma (ESCC) patients and construction of a nomogram to predict overall survival

The Prognostic Value of EGFR Overexpression and Amplification in Esophageal Squamous Cell Carcinoma

Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma

EXPREESION OF SOX4 SIGNIFICANTLY PREDICTS THE RISK OF LYMPH NODE METASTASIS FOR PATIENTS WITH EARLY-STAGE ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Clinicopathological Significance Of Sox4, Beta-Catenin, And Tcf4 Expression In Esophageal Squamous Cell Carcinoma

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

Epidermal Growth Factor Receptor Protein Overexpression and Gene Amplification Are Associated with Aggressive Biological Behaviors of Esophageal Squamous Cell Carcinoma.

Protein Overexpression and Gene Amplification of EGFR in Esophageal Squamous Cell Carcinoma: Relationship Between Malignant Biologic Behavior and EGFR Status Study.

Expression of SOX4 Significantly Predicts the Risk of Lymph Node Metastasis for Patients With Early-Stage Esophageal Squamous Cell Carcinoma

Evaluation of the Correlativity of Gender Determining Region Y-box 4, N-cadherin, CD44 and E-cadherin Expression in the Prognosis of Esophageal Squamous Cell Carcinoma.

SOX2 Expression is Associated with FGFR Fusion Genes and Predicts Favorable Outcome in Lung Squamous Cell Carcinomas.

Overexpression of Long Non-Coding RNA SOX2OT Promotes Esophageal Squamous Cell Carcinoma Growth

Prognostic Significance of CDK6 Amplification in Esophageal Squamous Cell Carcinoma

Increased Expression of HMGB 3 : a Novel Independent Prognostic Marker of Worse Outcome in Patients with Esophageal Squamous Cell Carcinoma

Prognostic Values of STAT 3 and HIF-1 Α in Esophageal Squamous Cell Carcinoma

Clinicopathological and Prognostic Characteristics of Esophageal Spindle Cell Squamous Cell Carcinoma: An Analysis of 43 Patients in a Single Center